NEW YORK (360Dx) – Inspirata said today that it has acquired Pittsburgh-based Omnyx from GE Healthcare in a deal that will enable it to deliver an IVD device for primary diagnosis in Europe and Canada.
Financial and other terms of the deal were not disclosed.
The acquisition of Omnyx positions Inspirata with a comprehensive digital pathology workflow solution, Inspirata CEO Satish Sanan said in a statement. "It brings us the last mile to reach our goal of having an end-to-end integrated pathology solution with a scanner-agnostic whole-slide-image viewer and image-management system," he said.
He noted that the deal also gives Tampa, Florida-based Inspirata "a fully supported IVD device cleared for primary digital diagnosis in Europe and Canada, and it expands our customer base and geographic footprint across those countries."
Inspirata, a cancer informatics and digital pathology workflow solution provider, said that it plans to retain Omnyxs' employees and will use the firm's office to create a center of excellence for ongoing digital pathology software development. "Our short-term plan is to rapidly combine the advantages of our digital pathology software platform and the Dynamyx platform by converging them onto a shared, state-of-the-art technology stack," Sanan said.
Omnyx CEO Andrew Chomos said that by combining platforms, "we will be able to offer a device and application-agnostic solution in both Europe and Canada that can integrate with pathology departments' existing hardware and health information systems."
Inspirata's flagship digital pathology software product, Dynamyx, uses the firm's solutions-as-a-service approach and is designed to enhance the pathology workflow by providing new channels for collaboration and tools to boost efficiency. The software is CE-marked in Europe and has received a license from Health Canada for in vitro diagnostic use.